{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:58:15Z","timestamp":1793642295382,"version":"4.5.1"},"reference-count":336,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["22QA1407100"],"award-info":[{"award-number":["22QA1407100"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103260"],"award-info":[{"award-number":["82103260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mtbio.2025.102585","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:50:21Z","timestamp":1764175821000},"page":"102585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Nanoparticle-based drug delivery systems in urologic oncology: From targeted therapy to precision theranostics"],"prefix":"10.1016","volume":"35","author":[{"given":"Jiayi","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlong","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5779-6682","authenticated-orcid":false,"given":"Kun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5975-2026","authenticated-orcid":false,"given":"Kai","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2022.07.032","article-title":"Tumors of the urinary system and Male genital organs: 2022 world health organization classification and multidisciplinarity","volume":"82","author":"Montironi","year":"2022","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12951-025-03106-6","article-title":"From micro to macro, nanotechnology demystifies acute pancreatitis: a new generation of treatment options emerges","volume":"23","author":"Du","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"13","key":"10.1016\/j.mtbio.2025.102585_bib3","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.addr.2013.09.019","article-title":"Nanomedicine therapeutic approaches to overcome cancer drug resistance","volume":"65","author":"Markman","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102585_bib4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.trecan.2021.05.001","article-title":"Nanomedicine-based strategies to target and modulate the tumor microenvironment","volume":"7","author":"Mendes","year":"2021","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib5","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 world health organization classification of tumors of the urinary system and Male genital organs-part B: prostate and urinary tract tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1200\/JCO.19.01638","article-title":"Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study","volume":"38","author":"Antonarakis","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib8","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","article-title":"Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries","volume":"6","author":"Zeng","year":"2018","journal-title":"Lancet Global Health"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib9","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033688","article-title":"Metastases in prostate cancer","volume":"9","author":"Manna","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","article-title":"Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice","volume":"20","author":"van Hoogstraten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European association of urology guidelines on renal cell carcinoma: the 2022 update","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and Male genital organs-part A: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.mtbio.2025.102585_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101335","article-title":"The molecular code of kidney cancer: a path of discovery for gene mutation and precision therapy","volume":"101","author":"Xie","year":"2025","journal-title":"Mol. Aspect. Med."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib15","first-page":"132","article-title":"Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: results from Canadian kidney cancer information system","volume":"15","author":"Sun","year":"2021","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.mtbio.2025.102585_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2020.01.011","article-title":"Targeting cancer cells with nanotherapeutics and nanodiagnostics: current status and future perspectives","volume":"69","author":"Ali","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib18","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/s41396-023-01483-0","article-title":"Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy","volume":"17","author":"Sun","year":"2023","journal-title":"ISME J."},{"issue":"12","key":"10.1016\/j.mtbio.2025.102585_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.44670","article-title":"Comparison of uptake and prices of biosimilars in the US, Germany, and Switzerland","volume":"5","author":"Carl","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1470-2045(09)70229-3","article-title":"Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target","volume":"10","author":"Chen","year":"2009","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5534\/wjmh.180040","article-title":"Role of androgen receptor in prostate cancer: a review","volume":"37","author":"Fujita","year":"2019","journal-title":"World J Mens Health"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib22","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S1470-2045(20)30449-6","article-title":"Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study","volume":"21","author":"Fizazi","year":"2020","journal-title":"Lancet Oncol."},{"issue":"13","key":"10.1016\/j.mtbio.2025.102585_bib23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"10398","key":"10.1016\/j.mtbio.2025.102585_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0140-6736(23)01055-3","article-title":"Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial","volume":"402","author":"Agarwal","year":"2023","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.mtbio.2025.102585_bib25","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1715546","article-title":"Apalutamide treatment and metastasis-free survival in prostate cancer","volume":"378","author":"Smith","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib26","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1016\/j.apsb.2024.07.003","article-title":"Strategies for intravesical drug delivery: from bladder physiological barriers and potential transport mechanisms","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib27","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1166\/jnn.2021.18651","article-title":"Mouse model to explore the therapeutic effect of nano-doxorubicin drug delivery system on bladder cancer","volume":"21","author":"Liu","year":"2021","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur. Urol."},{"issue":"18","key":"10.1016\/j.mtbio.2025.102585_bib29","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2018.4657","article-title":"Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial","volume":"319","author":"Messing","year":"2018","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102585_bib31","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.euo.2024.06.005","article-title":"The role of mitomycin C in intermediate-risk non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"7","author":"Scilipoti","year":"2024","journal-title":"Eur. Urol. Oncol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib32","first-page":"43","article-title":"Non-muscle-invasive bladder cancer: overview and contemporary treatment landscape of neoadjuvant chemoablative therapies","volume":"22","author":"Matulewicz","year":"2020","journal-title":"Rev. Urol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur. Urol."},{"issue":"28","key":"10.1016\/j.mtbio.2025.102585_bib34","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1200\/JCO.21.01003","article-title":"Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive bladder cancer","volume":"39","author":"Rose","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102585_bib35","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.mtbio.2025.102585_bib36","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2010.32.3139","article-title":"International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial","volume":"29","author":"Griffiths","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","article-title":"Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Motzer","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.mtbio.2025.102585_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"10.1016\/j.mtbio.2025.102585_bib39","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Rini","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1832348","article-title":"Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions","volume":"9","author":"Incorvaia","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.mtbio.2025.102585_bib41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semcancer.2019.08.013","article-title":"Nanomaterials multifunctional behavior for enlightened cancer therapeutics","volume":"69","author":"Raju","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"12","key":"10.1016\/j.mtbio.2025.102585_bib42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nchembio840","article-title":"New approaches to molecular cancer therapeutics","volume":"2","author":"Collins","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.mtbio.2025.102585_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biomaterials.2017.09.017","article-title":"Nanomaterials for cancer immunotherapy","volume":"148","author":"Song","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2025.102585_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.126999","article-title":"Nanoparticle-enhanced drug delivery systems: an up-to-date review","volume":"424","author":"Chenxi","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.mtbio.2025.102585_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.631351","article-title":"Designing and immunomodulating multiresponsive nanomaterial for cancer theranostics","volume":"8","author":"Khan","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.mtbio.2025.102585_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: advancements and innovation in the manufacturing process","volume":"154\u2013155","author":"Shah","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2025.102585_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2019.12.023","article-title":"The role of liposomes in clinical nanomedicine development. What now? Now what?","volume":"318","author":"Crommelin","year":"2020","journal-title":"J. Contr. Release"},{"issue":"29","key":"10.1016\/j.mtbio.2025.102585_bib48","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2217\/nnm-2021-0329","article-title":"Doxorubicin nanomedicine based on ginsenoside Rg1 with alleviated cardiotoxicity and enhanced antitumor activity","volume":"16","author":"Li","year":"2021","journal-title":"Nanomedicine (Lond)."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib49","first-page":"69","article-title":"Nanomedicine\u2010boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma","volume":"9","author":"Lu","year":"2022","journal-title":"Mil Med Res"},{"issue":"12","key":"10.1016\/j.mtbio.2025.102585_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.100964","article-title":"Progress and application of intelligent nanomedicine in urinary system tumors","volume":"14","author":"Xiao","year":"2024","journal-title":"J. Pharm. Anal."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41578-020-00277-6","article-title":"Extracellular vesicles versus synthetic nanoparticles for drug delivery","volume":"6","author":"Witwer","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.mtbio.2025.102585_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114990","article-title":"Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications","volume":"200","author":"Jeong","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2025.102585_bib53","article-title":"Nanostructures for cancer therapeutics and diagnostics: recent advances and future outlook","volume":"226","author":"Elabed","year":"2025","journal-title":"Radiat Phys Chem Oxf Engl 1993"},{"key":"10.1016\/j.mtbio.2025.102585_bib54","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.carbpol.2018.08.141","article-title":"pH-responsive hyaluronate-anchored extracellular vesicles to promote tumor-targeted drug delivery","volume":"202","author":"Lee","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.apsb.2021.05.016","article-title":"Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy","volume":"12","author":"Ma","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"19","key":"10.1016\/j.mtbio.2025.102585_bib56","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.3390\/molecules27196473","article-title":"Biomimetic targeted theranostic nanoparticles for breast cancer treatment","volume":"27","author":"Marshall","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.mtbio.2025.102585_bib57","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.2147\/IJN.S362192","article-title":"Update on the use of PET\/MRI contrast agents and tracers in brain oncology: a systematic review","volume":"17","author":"Smeraldo","year":"2022","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1449","article-title":"Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment","volume":"9","author":"Riley","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib59","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/acsnano.0c10276","article-title":"Tumor-selective immune-active mild hyperthermia associated with chemotherapy in Colon peritoneal metastasis by photoactivation of fluorouracil-gold nanoparticle complexes","volume":"15","author":"Mulens-Arias","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.molpharmaceut.8b00810","article-title":"Gold nanoparticles in cancer treatment","volume":"16","author":"Sztandera","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mtbio.2025.102585_bib61","series-title":"Chapter 17 - Gold Nanoparticles for Photothermal and Photodynamic Therapy","first-page":"619","author":"Sahoo","year":"2025"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12943-023-01798-8","article-title":"Gold nanoparticles and gold nanorods in the landscape of cancer therapy","volume":"22","author":"Kesharwani","year":"2023","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102585_bib63","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/ijms19071979","article-title":"Gold nanoparticles in diagnostics and therapeutics for human cancer","volume":"19","author":"Singh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib64","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3390\/molecules26051299","article-title":"Colloidal stability and cytotoxicity of polydopamine-conjugated gold nanorods against prostate cancer cell lines","volume":"26","author":"Mahmoud","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.mtbio.2025.102585_bib65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.biomaterials.2019.05.009","article-title":"Gold-caged copolymer nanoparticles as multimodal synergistic photodynamic\/photothermal\/chemotherapy platform against lethality androgen-resistant prostate cancer","volume":"212","author":"Wang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2025.102585_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119319","article-title":"The ligand exchange of citrates to thioabiraterone on gold nanoparticles for prostate cancer therapy","volume":"583","author":"Stolarczyk","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2025.102585_bib67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/NSA.S437812","article-title":"Green nanotechnology of yucca filamentosa- phytochemicals-functionalized gold nanoparticles-antitumor efficacy against prostate and breast cancers","volume":"16","author":"Thipe","year":"2023","journal-title":"Nanotechnol. Sci. Appl."},{"issue":"7","key":"10.1016\/j.mtbio.2025.102585_bib68","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/pharmaceutics13071094","article-title":"Phosphatidylserine-gold nanoparticles (PS-AuNP) induce prostate and breast cancer cell apoptosis","volume":"13","author":"Radaic","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12951-021-01019-8","article-title":"Formulating RALA\/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment","volume":"19","author":"Bennie","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401929","article-title":"PSMA-targeting imprinted nanogels for prostate tumor localization and imaging","volume":"14","author":"Zhang","year":"2025","journal-title":"Adv. Healthcare Mater."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib71","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1021\/acs.nanolett.0c02487","article-title":"Targeted radiosensitizers for MR-Guided radiation therapy of prostate cancer","volume":"20","author":"Luo","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2025.102585_bib72","article-title":"PSMA1-mediated ultrasmall gold nanoparticles facilitate tumor targeting and MR\/CT\/NIRF multimodal detection of early-stage prostate cancer","volume":"47","author":"Wang","year":"2022","journal-title":"Nanomedicine (Lond)."},{"key":"10.1016\/j.mtbio.2025.102585_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2022.133046","article-title":"Multifunctional nanocone array as solid immunoassay plate and SERS substrate for the early diagnosis of prostate cancer on microfluidic chip","volume":"376","author":"Lu","year":"2023","journal-title":"Sensor. Actuator. B Chem."},{"issue":"13","key":"10.1016\/j.mtbio.2025.102585_bib74","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1039\/C9AN00733D","article-title":"Vertical flow assays based on core\u2013shell SERS nanotags for multiplex prostate cancer biomarker detection","volume":"144","author":"Chen","year":"2019","journal-title":"Analyst"},{"key":"10.1016\/j.mtbio.2025.102585_bib75","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bios.2016.12.048","article-title":"Electrochemical bioassay development for ultrasensitive aptasensing of prostate specific antigen","volume":"91","author":"Heydari-Bafrooei","year":"2017","journal-title":"Biosens. Bioelectron."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib76","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00604-020-04573-4","article-title":"Surface plasmon resonance biosensor using hydrogel-AuNP supramolecular spheres for determination of prostate cancer-derived exosomes","volume":"187","author":"Chen","year":"2020","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.mtbio.2025.102585_bib77","article-title":"Ultrasensitive detection of 5-hydroxymethylcytosine in genomic DNA using a graphene-based sensor modified with biotin and gold nanoparticles","volume":"27","author":"Imran","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2025.102585_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2023.107363","article-title":"Gold nanorods assisted photothermal therapy of bladder cancer in mice: a computational study on the effects of gold nanorods distribution at the centre, periphery, and surface of bladder cancer","volume":"230","author":"Cheong","year":"2023","journal-title":"Comput. Methods Progr. Biomed."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib79","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/adba2e","article-title":"Gold nanoparticles\/Cu decorated metal-organic frameworks for synergistic photodynamic\/ferroptosis cancer therapy","volume":"20","author":"Zhao","year":"2025","journal-title":"Biomed. Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib80","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1038\/s41467-022-32474-y","article-title":"Pro-oxidant response and accelerated ferroptosis caused by synergetic Au(I) release in hypercarbon-centered gold(I) cluster prodrugs","volume":"13","author":"Xiao","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib81","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3390\/cancers14102413","article-title":"Gold glyconanoparticles combined with 91-99 peptide of the bacterial toxin, listeriolysin O, are efficient immunotherapies in experimental bladder tumors","volume":"14","author":"Ter\u00e1n-Navarro","year":"2022","journal-title":"Cancers (Basel)."},{"issue":"37","key":"10.1016\/j.mtbio.2025.102585_bib82","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2411583121","article-title":"Gold nanorod-assisted theranostic solution for nonvisible residual disease in bladder cancer","volume":"121","author":"Armanetti","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"19","key":"10.1016\/j.mtbio.2025.102585_bib83","doi-asserted-by":"crossref","first-page":"18932","DOI":"10.1021\/acsnano.3c04175","article-title":"Elevating second near-infrared photothermal conversion efficiency of hollow gold nanorod for a precise theranostic of orthotopic bladder cancer","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12951-023-02028-5","article-title":"A simple and robust nanosystem for photoacoustic imaging of bladder cancer based on \u03b15\u03b21-targeted gold nanorods","volume":"21","author":"Alfano","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202403314","article-title":"Urine-stable aptamer-conjugated gold nanorods for the early detection of high-grade bladder cancer residual disease","volume":"14","author":"Venegoni","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2025.102585_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.pacs.2022.100400","article-title":"Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods","volume":"28","author":"Alchera","year":"2022","journal-title":"Photoacoustics"},{"key":"10.1016\/j.mtbio.2025.102585_bib87","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.2147\/IJN.S203222","article-title":"Apoptotic effect of green synthesized gold nanoparticles from curcuma wenyujin extract against human renal cell carcinoma A498 cells","volume":"14","author":"Liu","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"23","key":"10.1016\/j.mtbio.2025.102585_bib88","doi-asserted-by":"crossref","first-page":"11331","DOI":"10.1039\/C9NR01198F","article-title":"Quantification of gold nanoparticle accumulation in tissue by two-photon luminescence microscopy","volume":"11","author":"Morales-Dalmau","year":"2019","journal-title":"Nanoscale"},{"issue":"12","key":"10.1016\/j.mtbio.2025.102585_bib89","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1039\/C8NR08790C","article-title":"Non-invasive and quantitative in vivo monitoring of gold nanoparticle concentration and tissue hemodynamics by hybrid optical spectroscopies","volume":"11","author":"Mireles","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.mtbio.2025.102585_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115550","article-title":"Site-specific detection of circulating tumor DNA methylation in biological samples utilizing phosphorothioated primer-based loop-mediated isothermal amplification","volume":"237","author":"Shen","year":"2023","journal-title":"Biosens. Bioelectron."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib91","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.advms.2021.07.003","article-title":"Serum and urine analysis with gold nanoparticle-assisted laser desorption\/ionization mass spectrometry for renal cell carcinoma metabolic biomarkers discovery","volume":"66","author":"Arendowski","year":"2021","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib92","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bios.2019.02.063","article-title":"Label-free impedimetric immunosensor based on arginine-functionalized gold nanoparticles for detection of DHEAS, a biomarker of pediatric adrenocortical carcinoma","volume":"133","author":"Lima","year":"2019","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.mtbio.2025.102585_bib93","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.aca.2019.01.003","article-title":"Colorimetric detection of normetanephrine, a pheochromocytoma biomarker, using bifunctionalised gold nanoparticles","volume":"1056","author":"Godoy-Reyes","year":"2019","journal-title":"Anal. Chim. Acta"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib94","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2174\/1871520619666190710121727","article-title":"Recent advances of silver nanoparticles in cancer diagnosis and treatment","volume":"20","author":"Huy","year":"2020","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib95","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1080\/03639045.2019.1656224","article-title":"Eco-friendly green synthesis of silver nanoparticles and their potential applications as antioxidant and anticancer agents","volume":"45","author":"Ahmed","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib96","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s11671-018-2728-6","article-title":"Insight into cellular uptake and intracellular trafficking of nanoparticles","volume":"13","author":"Foroozandeh","year":"2018","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.mtbio.2025.102585_bib97","doi-asserted-by":"crossref","first-page":"9091","DOI":"10.2147\/IJN.S447645","article-title":"Silver nanoparticles (AgNPs) uptake by caveolae-dependent endocytosis is responsible for their selective effect towards castration resistant prostate cancer","volume":"19","author":"Morais","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2025.102585_bib98","article-title":"Cytotoxicity and genotoxicity of biogenic silver nanoparticles in A549 and BEAS-2B cell lines","volume":"2022","author":"Muhamad","year":"2022","journal-title":"Bioinorgan. Chem. Appl."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib99","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12989-021-00430-1","article-title":"The mechanism of cell death induced by silver nanoparticles is distinct from silver cations","volume":"18","author":"Rohde","year":"2021","journal-title":"Part. Fibre Toxicol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib100","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/life13020466","article-title":"The role of silver nanoparticles in the diagnosis and treatment of cancer: are there any perspectives for the future?","volume":"13","author":"Takac","year":"2023","journal-title":"Life"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib101","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nano.2015.10.015","article-title":"Silver nanoparticles modulate ABC transporter activity and enhance chemotherapy in multidrug resistant cancer","volume":"12","author":"Kov\u00e1cs","year":"2016","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib102","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s12011-020-02255-z","article-title":"Silver nanoparticles synthesized using Carica papaya leaf extract (AgNPs-PLE) causes cell cycle arrest and apoptosis in human prostate (DU145) cancer cells","volume":"199","author":"Singh","year":"2021","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.mtbio.2025.102585_bib103","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.2147\/IJN.S364862","article-title":"Glucose-functionalized silver nanoparticles as a potential new therapy agent targeting hormone-resistant prostate cancer cells","volume":"17","author":"Morais","year":"2022","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib104","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3390\/pharmaceutics15030962","article-title":"A comparative study of cancer cells susceptibility to silver nanoparticles produced by electron beam","volume":"15","author":"Plotnikov","year":"2023","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib105","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/nano13101624","article-title":"Green nanoformulations of polyvinylpyrrolidone-capped metal nanoparticles: a study at the hybrid interface with biomimetic cell membranes and in vitro cell models","volume":"13","author":"Foti","year":"2023","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib106","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/nano11020256","article-title":"Starch-capped AgNPs' as potential cytotoxic agents against prostate cancer cells","volume":"11","author":"Morais","year":"2021","journal-title":"Nanomaterials"},{"issue":"19","key":"10.1016\/j.mtbio.2025.102585_bib107","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.3390\/molecules27196304","article-title":"Silver nanoparticles formulation of flower head's polyphenols of Cynara scolymus L.: a promising candidate against prostate (PC-3) cancer cell line through apoptosis activation","volume":"27","author":"Khedr","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.mtbio.2025.102585_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114978","article-title":"A novel peptide-templated AgNPs nanoprobe for theranostics of prostate cancer","volume":"223","author":"Cheng","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.mtbio.2025.102585_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2022.123886","article-title":"Introducing AgNPs-VB(2) composites as the dual signal quenching of CeO(2)-AuNPs-g-CNQDs hybrids for ultrasensitive \"on-off\" electrochemiluminescence immunosensing of prostate specific antigen","volume":"252","author":"Liu","year":"2023","journal-title":"Talanta"},{"key":"10.1016\/j.mtbio.2025.102585_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.113963","article-title":"Synergistic enhancement mediated sensitive SERS-Based immunoassay of PSA using versatile PDMS@AgNPs@ZIF-67 biomimetic substrates","volume":"239","author":"Zhao","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib111","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00604-023-05680-8","article-title":"Chitosan\/luminol\/AgNPs nanocomposite for electrochemiluminescent determination of prostate-specific antigen","volume":"190","author":"Nasrollahpour","year":"2023","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.mtbio.2025.102585_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2021.107744","article-title":"The electrochemical immunosensor for detection of prostatic specific antigen using quince seed mucilage-GNPs-SNPs as a green composite","volume":"139","author":"Darvishi","year":"2021","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.mtbio.2025.102585_bib113","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejpb.2020.04.012","article-title":"Biogenic silver nanoparticles: in vitro and in vivo antitumor activity in bladder cancer","volume":"151","author":"Ferreira","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib114","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4068\/cmj.2022.58.3.102","article-title":"Silver nanoparticles exert apoptotic activity in bladder cancer 5637 cells through alteration of Bax\/Bcl-2 genes expression","volume":"58","author":"Daei","year":"2022","journal-title":"Chonnam Med J"},{"issue":"9","key":"10.1016\/j.mtbio.2025.102585_bib115","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.3390\/nano11092384","article-title":"Detection of circulating serum protein biomarkers of non-muscle invasive bladder cancer after protein corona-silver nanoparticles analysis by SWATH-MS","volume":"11","author":"G\u00f3mez","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.mtbio.2025.102585_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.342770","article-title":"A highly sensitive SERS substrate of porous membrane-Ag NPs for kidney cancer detection","volume":"1315","author":"Chen","year":"2024","journal-title":"Anal. Chim. Acta"},{"issue":"16","key":"10.1016\/j.mtbio.2025.102585_bib117","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1007\/s00216-021-03381-w","article-title":"Identifying functioning and nonfunctioning adrenal tumors based on blood serum surface-enhanced Raman spectroscopy","volume":"413","author":"Chen","year":"2021","journal-title":"Anal. Bioanal. Chem."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102585_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901058","article-title":"Magnetic nanoparticles in cancer therapy and diagnosis","volume":"9","author":"Farzin","year":"2020","journal-title":"Adv. Healthcare Mater."},{"issue":"8","key":"10.1016\/j.mtbio.2025.102585_bib119","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1021\/acsabm.1c00440","article-title":"Magnetic nanoparticles for biomedical applications: from the soul of the Earth to the deep history of ourselves","volume":"4","author":"Martins","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304848","article-title":"Magnetic nanoparticles: a review on synthesis, characterization, functionalization, and biomedical applications","volume":"20","author":"Rezaei","year":"2024","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib121","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s44222-024-00257-3","article-title":"Imaging-guided precision hyperthermia with magnetic nanoparticles","volume":"3","author":"Shakeri-Zadeh","year":"2024","journal-title":"Nature Reviews Bioengineering"},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib122","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s41365-024-01527-w","article-title":"Structural control of magnetic nanoparticles for positive nuclear magnetic resonance imaging","volume":"35","author":"Ali","year":"2024","journal-title":"Nucl. Sci. Tech."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102585_bib123","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/RLI.0000000000001046","article-title":"Subnodal correspondence of PSMA expression and USPIO-MRI in metastatic pelvic lymph nodes in prostate cancer","volume":"59","author":"Schilham","year":"2024","journal-title":"Investig. Radiol."},{"issue":"7","key":"10.1016\/j.mtbio.2025.102585_bib124","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1021\/acs.nanolett.0c04455","article-title":"Mixed metal metal-organic frameworks derived carbon supporting ZnFe(2)O(4)\/C for high-performance magnetic particle imaging","volume":"21","author":"Jiang","year":"2021","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/j.mtbio.2025.102585_bib125","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1021\/acsnano.4c16981","article-title":"Nanovesicles for lipid metabolism reprogram-enhanced ferroptosis and magnetotherapy of refractory tumors and inhibiting metastasis with activated innate immunity","volume":"19","author":"Cheng","year":"2025","journal-title":"ACS Nano"},{"issue":"25","key":"10.1016\/j.mtbio.2025.102585_bib126","doi-asserted-by":"crossref","first-page":"30008","DOI":"10.1021\/acsami.3c07248","article-title":"Cell-membrane-coated and cell-penetrating peptide-conjugated trimagnetic nanoparticles for targeted magnetic hyperthermia of prostate cancer cells","volume":"15","author":"Nica","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2025.102585_bib127","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.2147\/IJN.S242359","article-title":"Magnetically directed enzyme\/prodrug prostate cancer therapy based on \u03b2-Glucosidase\/Amygdalin","volume":"15","author":"Zhou","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"12","key":"10.1016\/j.mtbio.2025.102585_bib128","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/jfb15120364","article-title":"Characteristics and antitumor activity of doxorubicin-loaded multifunctional iron oxide nanoparticles in MEC1 and RM1 cell lines","volume":"15","author":"Maisuradze","year":"2024","journal-title":"J. Funct. Biomater."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib129","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/pharmaceutics12111020","article-title":"Systemically delivered magnetic hyperthermia for prostate cancer treatment","volume":"12","author":"Albarqi","year":"2020","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.mtbio.2025.102585_bib130","doi-asserted-by":"crossref","first-page":"11611","DOI":"10.1021\/acsami.4c16009","article-title":"Optical and MRI-guided theranostic application of ultrasmall superparamagnetic iron oxide nanodrug conjugate for PSMA-positive prostate cancer therapy","volume":"17","author":"Surasinghe","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"14","key":"10.1016\/j.mtbio.2025.102585_bib131","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1039\/D2BM00107A","article-title":"The improved killing of both androgen-dependent and independent prostate cancer cells by etoposide loaded SPIONs coupled with NIR irradiation","volume":"10","author":"Onbasli","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122328","article-title":"Curcumin loaded \u03b2-cyclodextrin-magnetic graphene oxide nanoparticles decorated with folic acid receptors as a new theranostic agent to improve prostate cancer treatment","volume":"340","author":"Einafshar","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.mtbio.2025.102585_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113445","article-title":"Modulating Treg cell activity in prostate cancer via chitosan nanoparticles loaded with si-BATF\/PRDM1","volume":"144","author":"Zhao","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib134","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401929","article-title":"PSMA-targeting imprinted nanogels for prostate tumor localization and imaging","volume":"14","author":"Zhang","year":"2025","journal-title":"Adv. Healthcare Mater."},{"issue":"24","key":"10.1016\/j.mtbio.2025.102585_bib135","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1039\/D0LC00677G","article-title":"Microfluidic Raman biochip detection of exosomes: a promising tool for prostate cancer diagnosis","volume":"20","author":"Wang","year":"2020","journal-title":"Lab Chip"},{"issue":"46","key":"10.1016\/j.mtbio.2025.102585_bib136","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1039\/D2TB01860H","article-title":"Transition-metal-doped hydrophilic ultrasmall iron oxide modulates MRI contrast performance for accurate diagnosis of orthotopic prostate cancer","volume":"10","author":"Xie","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"8","key":"10.1016\/j.mtbio.2025.102585_bib137","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00604-021-04934-7","article-title":"Rapid and specific detection nanoplatform of serum exosomes for prostate cancer diagnosis","volume":"188","author":"Li","year":"2021","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.mtbio.2025.102585_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122008","article-title":"Synthesis and in vitro proof-of-concept studies on bispecific iron oxide magnetic nanoparticles targeting PSMA and GRP receptors for PET\/MR imaging of prostate cancer","volume":"624","author":"Liolios","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"19","key":"10.1016\/j.mtbio.2025.102585_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910334","article-title":"Application of H(2)N-Fe(3)O(4) nanoparticles for prostate cancer magnetic resonance imaging in an animal model","volume":"25","author":"Blasiak","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102585_bib140","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax6040","article-title":"Sight and switch off: nerve density visualization for interventions targeting nerves in prostate cancer","volume":"6","author":"You","year":"2020","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib141","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/pharmaceutics14102051","article-title":"Glu-urea-lys scaffold functionalized superparamagnetic iron oxide nanoparticles targeting PSMA for in vivo molecular MRI of prostate cancer","volume":"14","author":"Zhou","year":"2022","journal-title":"Pharmaceutics"},{"issue":"14","key":"10.1016\/j.mtbio.2025.102585_bib142","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/nano14141177","article-title":"Bimodal MRI\/fluorescence nanoparticle imaging contrast agent targeting prostate cancer","volume":"14","author":"Xu","year":"2024","journal-title":"Nanomaterials"},{"key":"10.1016\/j.mtbio.2025.102585_bib143","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.2147\/IJN.S324354","article-title":"Specific binding of novel SPION-based system bearing Anti-N-Cadherin antibodies to prostate tumor cells","volume":"16","author":"Karnas","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"41","key":"10.1016\/j.mtbio.2025.102585_bib144","doi-asserted-by":"crossref","first-page":"36158","DOI":"10.1021\/acsnano.5c04774","article-title":"Engineered magnetic resonance nanoprobes for visualizing tumor programmed cell death ligand 1 level and enhancing synergistic radio immunotherapy","volume":"19","author":"Sun","year":"2025","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib145","article-title":"The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy","volume":"57","author":"Li","year":"2025","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib146","doi-asserted-by":"crossref","DOI":"10.1097\/ot9.0000000000000099","article-title":"Predictive factors of treatment efficacy and prognosis in patients with resectable non\u2013small cell lung cancer following neoadjuvant chemoimmunotherapy","volume":"11","author":"Chen","year":"2025","journal-title":"Oncology and Translational Medicine"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib147","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3390\/pharmaceutics15030850","article-title":"Multimodal radiobioconjugates of magnetic nanoparticles labeled with (44)Sc and (47)Sc for Theranostic application","volume":"15","author":"\u00fcnak","year":"2023","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib148","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.3390\/biomedicines11102779","article-title":"A fluorescent and magnetic hybrid tracer for improved sentinel lymphadenectomy in prostate cancer patients","volume":"11","author":"Engels","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib149","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12951-024-02704-0","article-title":"Integration of photomagnetic bimodal imaging to monitor an autogenous exosome loaded platform: unveiling strong targeted retention effects for guiding the photothermal and magnetothermal therapy in a mouse prostate cancer model","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2025.102585_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122514","article-title":"Mild magnetic hyperthermia-activated immuno-responses for primary bladder cancer therapy","volume":"307","author":"Qi","year":"2024","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.mtbio.2025.102585_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202306699","article-title":"Engineered macrophages tune intratumoral cytokines through precisely controlled self-pyroptosis to enhance bladder cancer immunotherapy","volume":"20","author":"Guo","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2025.102585_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113664","article-title":"Boosting chemotherapy of bladder cancer cells by ferroptosis using intelligent magnetic targeting nanoparticles","volume":"234","author":"Cai","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.mtbio.2025.102585_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.958072","article-title":"Improvement of the bladder perfusion curative effect through tight junction protein degradation induced by magnetic temperature-sensitive hydrogels","volume":"10","author":"Sun","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.mtbio.2025.102585_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138412","article-title":"Chitosan\/polyvinyl alcohol-based magnetic hydrogel microspheres with controlled retention and regulated drug release for intravesical instillation","volume":"287","author":"Yin","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2025.102585_bib155","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.2147\/DDDT.S490652","article-title":"Magnetic-powered spora lygodii microrobots loaded with doxorubicin for active and targeted therapy of bladder cancer","volume":"18","author":"Yang","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"issue":"26","key":"10.1016\/j.mtbio.2025.102585_bib156","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201042","article-title":"Magnetic-powered Janus cell robots loaded with oncolytic adenovirus for active and targeted virotherapy of bladder cancer","volume":"34","author":"Cong","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.102585_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463279","article-title":"Magnetic multi-enzyme cascade combined with liquid chromatography tandem mass spectrometry for fast DNA digestion and quantitative analysis of 5-hydroxymethylcytosine in genome of human bladder cancer T24 cells induced by tetrachlorobenzoquinone","volume":"1676","author":"Fang","year":"2022","journal-title":"J. Chromatogr. A"},{"issue":"26","key":"10.1016\/j.mtbio.2025.102585_bib158","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1021\/acsnano.4c04303","article-title":"Imaging and downstaging bladder cancer with the (177)Lu-Labeled bioorthogonal nanoprobe","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib159","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1021\/acsbiomaterials.1c01217","article-title":"Fe(III)-Doped polyaminopyrrole nanoparticle for imaging-guided photothermal therapy of bladder cancer","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/life11010071","article-title":"Smart nanoformulation based on polymeric magnetic nanoparticles and vincristine drug: a novel therapy for apoptotic gene expression in tumors","volume":"11","author":"Al-Musawi","year":"2021","journal-title":"Life"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib161","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/01.ju.0000170234.14519.19","article-title":"Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer","volume":"174","author":"Tabatabaei","year":"2005","journal-title":"J. Urol."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib162","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.3390\/molecules27113520","article-title":"Dual-template magnetic molecularly imprinted polymer for simultaneous determination of spot urine metanephrines and 3-Methoxytyramine for the diagnosis of pheochromocytomas and paragangliomas","volume":"27","author":"Zeng","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib163","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12645-024-00250-w","article-title":"Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics","volume":"15","author":"Dutta Gupta","year":"2024","journal-title":"Cancer Nanotechnol"},{"key":"10.1016\/j.mtbio.2025.102585_bib164","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.2147\/IJN.S498729","article-title":"A novel approach for bladder cancer treatment: nanoparticles as a drug delivery system","volume":"19","author":"Zhao","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib165","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","article-title":"Multifunctional mesoporous silica nanoparticles for biomedical applications","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2025.102585_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114534","article-title":"Hollow mesoporous silica nanoparticles for drug formulation and delivery: opportunities for cancer therapy","volume":"249","author":"Guo","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102585_bib167","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202408898","article-title":"Smart mesoporous silica nanoparticles in cancer: diagnosis, treatment, immunogenicity, and clinical translation","volume":"21","author":"Yousefiasl","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2025.102585_bib168","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.micromeso.2016.08.038","article-title":"Stimuli-responsive mesoporous silica nanoparticles for cancer therapy: a review","volume":"236","author":"Moreira","year":"2016","journal-title":"Microporous Mesoporous Mater."},{"issue":"39","key":"10.1016\/j.mtbio.2025.102585_bib169","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202303269","article-title":"Design and synthesis of cabazitaxel loaded core-shell mesoporous silica nanoparticles with different morphologies for prostate cancer therapy","volume":"20","author":"Mohanan","year":"2024","journal-title":"Small"},{"issue":"28","key":"10.1016\/j.mtbio.2025.102585_bib170","doi-asserted-by":"crossref","first-page":"12008","DOI":"10.1039\/D3NR01571H","article-title":"Super-resolution imaging of antibody-conjugated biodegradable periodic mesoporous organosilica nanoparticles for targeted chemotherapy of prostate cancer","volume":"15","author":"Das","year":"2023","journal-title":"Nanoscale"},{"issue":"18","key":"10.1016\/j.mtbio.2025.102585_bib171","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1039\/D2NR00783E","article-title":"Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells","volume":"14","author":"Tiburcius","year":"2022","journal-title":"Nanoscale"},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib172","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1021\/acsbiomaterials.1c00066","article-title":"Development of thiabendazole-loaded mesoporous silica nanoparticles for cancer therapy","volume":"8","author":"Esfahani","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib173","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/pharmaceutics14040884","article-title":"\u03b2-Lactoglobulin-Modified mesoporous silica nanoparticles: a promising carrier for the targeted delivery of fenbendazole into prostate cancer cells","volume":"14","author":"Koohi","year":"2022","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.mtbio.2025.102585_bib174","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.3390\/nano12213835","article-title":"Mesoporous silica and oligo (ethylene glycol) methacrylates-based dual-responsive hybrid nanogels","volume":"12","author":"Macchione","year":"2022","journal-title":"Nanomaterials"},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib175","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/pharmaceutics13101605","article-title":"PEGylated mesoporous silica nanoparticles (MCM-41): a promising carrier for the targeted delivery of fenbendazole into prostrate cancer cells","volume":"13","author":"Esfahani","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102585_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109614","article-title":"PSA targeted dual-modality manganese oxide\u2013mesoporous silica nanoparticles for prostate cancer imaging","volume":"121","author":"Du","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"14","key":"10.1016\/j.mtbio.2025.102585_bib177","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1039\/D3BM00631J","article-title":"Targeted hollow pollen silica nanoparticles for enhanced intravesical therapy of bladder cancer","volume":"11","author":"Wang","year":"2023","journal-title":"Biomater. Sci."},{"issue":"7","key":"10.1016\/j.mtbio.2025.102585_bib178","article-title":"Thiolated mesoporous silica nanoparticles as an immunoadjuvant to enhance efficacy of intravesical chemotherapy for bladder cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"33","key":"10.1016\/j.mtbio.2025.102585_bib179","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1021\/acs.nanolett.4c02485","article-title":"Targeted inhibition of lymphovascular invasion formation with CREKA peptide-modified silicasomes to boost chemotherapy in bladder cancer","volume":"24","author":"Wu","year":"2024","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib180","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.actbio.2025.03.032","article-title":"Effective delivery of CRISPR\/dCas9-SAM for multiplex gene activation based on mesoporous silica nanoparticles for bladder cancer therapy","volume":"197","author":"Xu","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2025.102585_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117185","article-title":"Carboxylated mesoporous silica nanoparticle-nucleic acid chimera conjugate-assisted delivery of siRNA and doxorubicin effectively treat drug-resistant bladder cancer","volume":"178","author":"Yang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"17","key":"10.1016\/j.mtbio.2025.102585_bib182","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1039\/D1TB02299G","article-title":"Spherical and rod shaped mesoporous silica nanoparticles for cancer-targeted and photosensitizer delivery in photodynamic therapy","volume":"10","author":"Borz\u0119cka","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102585_bib183","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/pharmaceutics12060505","article-title":"Particle-size-dependent delivery of antitumoral miRNA using targeted mesoporous silica nanoparticles","volume":"12","author":"Haddick","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102585_bib184","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1039\/D4NA00823E","article-title":"Binding affinity and transport studies of engineered photocrosslinkable affibody-enzyme-nanoparticle constructs","volume":"8","author":"Curry","year":"2025","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.mtbio.2025.102585_bib185","article-title":"Photothermal therapy enhance the anti-mitochondrial metabolism effect of lonidamine to renal cell carcinoma in homologous-targeted nanosystem","volume":"34","author":"Chen","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.mtbio.2025.102585_bib186","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jconrel.2025.02.007","article-title":"Precise identification of bladder tumors utilizing mucoadhesive thiolated hollow mesoporous silica nanoparticles","volume":"380","author":"Fa","year":"2025","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.mtbio.2025.102585_bib187","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1021\/acs.analchem.3c05204","article-title":"Amplification-free analysis of bladder cancer MicroRNAs on wrinkled silica nanoparticles with DNA-functionalized quantum dots","volume":"96","author":"Wang","year":"2024","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib188","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2025.102585_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107871","article-title":"Clinical therapies and nano drug delivery systems for urinary bladder cancer","volume":"226","author":"Jain","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.urolonc.2023.11.022","article-title":"A systematic review of nanocarriers for treatment of urologic cancers","volume":"42","author":"Wang","year":"2024","journal-title":"Urol. Oncol."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102585_bib191","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.trecan.2020.02.017","article-title":"Lipid in renal carcinoma: queen bee to target?","volume":"6","author":"Tan","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.mtbio.2025.102585_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121023","article-title":"Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection","volume":"607","author":"Khater","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2025.102585_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102585_bib194","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41419-024-06776-6","article-title":"A novel doxorubicin\/CTLA-4 blocker co-loaded drug delivery system improves efficacy and safety in antitumor therapy","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mtbio.2025.102585_bib195","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.actbio.2021.12.019","article-title":"Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy","volume":"140","author":"Pereira","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2025.102585_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122379","article-title":"A liposomal formulation of simvastatin and doxorubicin for improved cardioprotective and anti-cancer effect","volume":"629","author":"Bj\u00f8rnstad","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib197","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/ijms25010115","article-title":"Co-Loading of black phosphorus nanoflakes and doxorubicin in lysolipid temperature-sensitive liposomes for combination therapy in prostate cancer","volume":"25","author":"Das","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106199","article-title":"Co-delivery of docetaxel and resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer","volume":"174","author":"Zhang","year":"2022","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib199","first-page":"379","article-title":"Concomitant delivery of doxorubicin and cisplatin through liposome-based thermosensitive nanoparticles: perspective in the treatment of cancer in animal models","volume":"13","author":"Maswadeh","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"8","key":"10.1016\/j.mtbio.2025.102585_bib200","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/nano12081274","article-title":"Liposomal nanoformulation as a carrier for curcumin and pEGCG-Study on stability and anticancer potential","volume":"12","author":"Piwowarczyk","year":"2022","journal-title":"Nanomaterials"},{"issue":"8","key":"10.1016\/j.mtbio.2025.102585_bib201","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3390\/antiox13080902","article-title":"The influence of \u03b2-Carotene and its liposomal form on the expression of EMT markers and androgen-dependent pathways in different prostate cell lines","volume":"13","author":"Duli\u0144ska-Litewka","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.mtbio.2025.102585_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111723","article-title":"PSMA conjugated combinatorial liposomal formulation encapsulating genistein and plumbagin to induce apoptosis in prostate cancer cells","volume":"203","author":"Tian","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib203","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.apsb.2020.08.001","article-title":"A facile and universal method to achieve liposomal remote loading of non-ionizable drugs with outstanding safety profiles and therapeutic effect","volume":"11","author":"Zhou","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"24","key":"10.1016\/j.mtbio.2025.102585_bib204","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202100478","article-title":"iRGD-liposomes enhance tumor delivery and therapeutic efficacy of antisense oligonucleotide drugs against primary prostate cancer and bone metastasis","volume":"31","author":"Guan","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2025.102585_bib205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2147\/IJN.S341824","article-title":"Cyclic RGD-decorated liposomal gossypol AT-101 targeting for enhanced antitumor effect","volume":"17","author":"Liu","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2025.102585_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121018","article-title":"Hypoxia-targeted cupric-tirapazamine liposomes potentiate radiotherapy in prostate cancer spheroids","volume":"607","author":"Silva","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2025.102585_bib207","article-title":"Anti-EGFR immunoliposomes for cabazitaxel delivery: from formulation development to in vivo evaluation in prostate cancer xenograft model","volume":"661","author":"Carolina","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.mtbio.2025.102585_bib208","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/pharmaceutics14081649","article-title":"Synthesis of novel arsonolipids and development of novel arsonoliposome types","volume":"14","author":"Mourtas","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib209","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41598-021-03324-6","article-title":"Gene therapy of prostate cancer using liposomes containing perforin expression vector driven by the promoter of prostate-specific antigen gene","volume":"12","author":"Mizutani","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib210","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00210-023-02752-7","article-title":"RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells","volume":"397","author":"Khosravani","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib211","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/21691401.2023.2247036","article-title":"Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes","volume":"51","author":"Pande","year":"2023","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib212","first-page":"1273","article-title":"State of the art of stimuli-responsive liposomes for cancer therapy","volume":"16","author":"Heidarli","year":"2017","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.mtbio.2025.102585_bib213","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.2147\/IJN.S204221","article-title":"Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC","volume":"14","author":"Pal","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2025.102585_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117398","article-title":"Preparation of photo-controlled release ROS-responsive Ce6\/elemene co-loaded liposomes and study on the effect on enhancing apoptosis of NMIBC","volume":"179","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib215","doi-asserted-by":"crossref","first-page":"676","DOI":"10.20892\/j.issn.2095-3941.2020.0454","article-title":"An ATF(24) peptide-functionalized \u03b2-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment","volume":"17","author":"Zhai","year":"2020","journal-title":"Cancer Biol Med"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib216","doi-asserted-by":"crossref","first-page":"60","DOI":"10.20892\/j.issn.2095-3941.2019.0156","article-title":"Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated \u03b2-elemene liposomes","volume":"17","author":"Zhai","year":"2020","journal-title":"Cancer Biol Med"},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib217","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/pharmaceutics12100996","article-title":"Targeting EphA2 in bladder cancer using a novel antibody-directed nanotherapeutic","volume":"12","author":"Kamoun","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib218","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/ijms21020559","article-title":"Enhanced efficacy of PEGylated liposomal cisplatin: in vitro and in vivo evaluation","volume":"21","author":"Ghaferi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111496","article-title":"Enhancing cardiac safety: liposomal ciprofloxacin mitigates anthracycline-induced cardiotoxicity without compromising anticancer efficacy","volume":"414","author":"Swiech","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102585_bib220","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s00262-021-02870-2","article-title":"The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8(+) T cells","volume":"70","author":"Shiga","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"issue":"12","key":"10.1016\/j.mtbio.2025.102585_bib221","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.3390\/cancers12123679","article-title":"Liposome-encapsulated bacillus calmette-gu\u00e9rin cell wall skeleton enhances antitumor efficiency for bladder cancer in vitro and in vivo via induction of AMP-activated protein kinase","volume":"12","author":"Whang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib222","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12944-025-02431-x","article-title":"SRT3025-loaded cell membrane hybrid liposomes (3025@ML) enhanced anti-tumor activity of oxaliplatin via inhibiting pyruvate kinase M2 and fatty acid synthase","volume":"24","author":"Wang","year":"2025","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib223","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12951-024-02664-5","article-title":"A multifunctional PEGylated liposomal-encapsulated sunitinib enhancing autophagy, immunomodulation, and safety in renal cell carcinoma","volume":"22","author":"Yueh","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"16","key":"10.1016\/j.mtbio.2025.102585_bib224","first-page":"20202","article-title":"Tumor supplying artery injection of liposome@sunitinib could effectively inhibit the progression of kidney tumor","volume":"16","author":"Fu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2025.102585_bib225","article-title":"Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways","volume":"8","author":"Wang","year":"2024","journal-title":"Int. J. Pharm. X"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib226","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12951-025-03170-y","article-title":"Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint inhibition to boost anticancer immunity","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib227","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13046-024-03079-8","article-title":"Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe","volume":"43","author":"Rachamala","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102585_bib228","doi-asserted-by":"crossref","first-page":"22711","DOI":"10.3390\/ijms160922711","article-title":"The use of a liposomal formulation incorporating an antimicrobial peptide from tilapia as a new adjuvant to epirubicin in human squamous cell carcinoma and pluripotent testicular embryonic carcinoma cells","volume":"16","author":"Lo","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib229","article-title":"Advances in targeted therapy for tumor with nanocarriers: a review","volume":"31","author":"Cheng","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"8","key":"10.1016\/j.mtbio.2025.102585_bib230","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/jpm12081334","article-title":"Dendrimers, an emerging opportunity in personalized medicine?","volume":"12","author":"Caminade","year":"2022","journal-title":"J. Personalized Med."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102585_bib231","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/pharmaceutics15061591","article-title":"Dendrimers in corneal drug delivery: recent developments and translational opportunities","volume":"15","author":"Dhull","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102585_bib232","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","article-title":"PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy","volume":"12","author":"Abedi-Gaballu","year":"2018","journal-title":"Appl. Mater. Today"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib233","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1039\/D3NR06520K","article-title":"PSMA-targeted dendrimer as an efficient anticancer drug delivery vehicle for prostate cancer","volume":"16","author":"Dhull","year":"2024","journal-title":"Nanoscale"},{"issue":"9","key":"10.1016\/j.mtbio.2025.102585_bib234","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1021\/acs.biomac.4c00878","article-title":"PSMA-targeted 2-Deoxyglucose-Based dendrimer nanomedicine for the treatment of prostate cancer","volume":"25","author":"Rani","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.mtbio.2025.102585_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122659","article-title":"Targeted silencing of the MCL-1 gene using multi-layered dendrimer-based nanoconstructs achieves efficient tumor regression in xenografted mice models","volume":"634","author":"Tambe","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib236","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1039\/D0BM01441A","article-title":"Octadecyl chain-bearing PEGylated poly(propyleneimine)-based dendrimersomes: physicochemical studies, redox-responsiveness, DNA condensation, cytotoxicity and gene delivery to cancer cells","volume":"9","author":"Laskar","year":"2021","journal-title":"Biomater. Sci."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib237","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/pharmaceutics13050676","article-title":"Targeted RNAi of BIRC5\/Survivin using antibody-conjugated Poly(Propylene Imine)-Based polyplexes inhibits growth of PSCA-positive tumors","volume":"13","author":"Jugel","year":"2021","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.mtbio.2025.102585_bib238","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1021\/acs.biomac.2c00899","article-title":"Alteration of the HIF-1\u03b1\/VEGF signaling pathway and disruption of the cell cycle by second generation carbosilan dendrimers","volume":"23","author":"Barrios","year":"2022","journal-title":"Biomacromolecules"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib239","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3390\/pharmaceutics14112456","article-title":"Gallic acid-triethylene glycol aptadendrimers synthesis, biophysical characterization and cellular evaluation","volume":"14","author":"Miranda","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102585_bib240","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/biom12060770","article-title":"Design, synthesis and characterization of [G10a]-Temporin SHa dendrimers as dual inhibitors of cancer and pathogenic microbes","volume":"12","author":"Khan","year":"2022","journal-title":"Biomolecules"},{"issue":"20","key":"10.1016\/j.mtbio.2025.102585_bib241","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1039\/D1NR00669J","article-title":"Dual contrast agents for fluorescence and photoacoustic imaging: evaluation in a murine model of prostate cancer","volume":"13","author":"Lesniak","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.mtbio.2025.102585_bib242","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.2147\/IJN.S454128","article-title":"Multimodal, PSMA-Targeted, PAMAM dendrimer-drug conjugates for treatment of prostate cancer: preclinical evaluation","volume":"19","author":"Lesniak","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102585_bib243","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/antiox9100993","article-title":"Carbosilane dendrimers loaded with siRNA targeting Nrf2 as a tool to overcome cisplatin chemoresistance in bladder cancer cells","volume":"9","author":"Ambrosio","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.mtbio.2025.102585_bib244","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.2147\/IJN.S140111","article-title":"Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation","volume":"12","author":"Qiu","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102585_bib245","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/cplu.201800370","article-title":"A galactose dendritic silicon (IV) phthalocyanine as a photosensitizing agent in cancer photodynamic therapy","volume":"83","author":"Bispo","year":"2018","journal-title":"ChemPlusChem"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib246","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1021\/jacs.9b10160","article-title":"Nanoparticle conjugation stabilizes and multimerizes \u03b2-Hairpin peptides to effectively target PD-1\/PD-L1 \u03b2-Sheet-Rich interfaces","volume":"142","author":"Jeong","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2025.102585_bib247","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2020.112250","article-title":"Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: from nanoscale analysis to clinical application","volume":"162","author":"Bu","year":"2020","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.mtbio.2025.102585_bib248","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trac.2015.06.014","article-title":"PLGA-based nanoparticles: a new paradigm in biomedical applications","volume":"80","author":"Sharma","year":"2016","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.mtbio.2025.102585_bib249","article-title":"Targeted therapy of breast tumor by PLGA-based nanostructures: the versatile function in doxorubicin delivery","volume":"233","author":"Sonam","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.mtbio.2025.102585_bib250","article-title":"PLGA nanomedical consignation: a novel approach for the management of prostate cancer","volume":"652","author":"Sonam","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"26","key":"10.1016\/j.mtbio.2025.102585_bib251","doi-asserted-by":"crossref","first-page":"16674","DOI":"10.1021\/acsnano.4c01640","article-title":"Enhanced prostate-specific membrane antigen targeting by precision control of DNA scaffolded nanoparticle ligand presentation","volume":"18","author":"Jana","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib252","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12929-022-00812-3","article-title":"Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer","volume":"29","author":"Liu","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117125","article-title":"PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer","volume":"177","author":"Adekiya","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib254","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/pharmaceutics14050964","article-title":"Development and evaluation of a PSMA-targeted nanosystem Co-Packaging docetaxel and androgen receptor siRNA for castration-resistant prostate cancer treatment","volume":"14","author":"Zhang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102585_bib255","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2147\/IJN.S301552","article-title":"Dual-functional PLGA nanoparticles Co-Loaded with indocyanine green and resiquimod for prostate cancer treatment","volume":"16","author":"Lin","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2025.102585_bib256","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ijbiomac.2022.12.172","article-title":"Onion-like doxorubicin-carrying polymeric nanomicelles with tumor acidity-sensitive dePEGylation to expose positively-charged chitosan shell for enhanced cancer chemotherapy","volume":"227","author":"Huang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib257","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/pharmaceutics15020662","article-title":"Cabazitaxel-loaded nanoparticles reduce the invasiveness in metastatic prostate cancer cells: beyond the classical taxane function","volume":"15","author":"Lampe","year":"2023","journal-title":"Pharmaceutics"},{"issue":"23","key":"10.1016\/j.mtbio.2025.102585_bib258","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1039\/D2TB00695B","article-title":"Tumor acidity-responsive polymeric nanoparticles to promote intracellular delivery of zoledronic acid by PEG detachment and positive charge exposure for enhanced antitumor potency","volume":"10","author":"Chou","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102322","article-title":"Highly efficient nucleic acid encapsulation method for targeted gene therapy using antibody conjugation system","volume":"35","author":"Hong","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102585_bib260","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1039\/D3BM01735D","article-title":"Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression","volume":"12","author":"Xiong","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib261","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1102651","article-title":"Photoacoustic signal enhancement in dual-contrast gastrin-releasing peptide receptor-targeted nanobubbles","volume":"11","author":"Zhao","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"46","key":"10.1016\/j.mtbio.2025.102585_bib262","doi-asserted-by":"crossref","first-page":"54739","DOI":"10.1021\/acsami.1c16383","article-title":"Synthesis and preliminary biological assessment of carborane-loaded theranostic nanoparticles to target prostate-specific membrane antigen","volume":"13","author":"Meher","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"28","key":"10.1016\/j.mtbio.2025.102585_bib263","doi-asserted-by":"crossref","first-page":"17377","DOI":"10.1021\/acsomega.0c01745","article-title":"Trimethoprim-loaded PLGA nanoparticles grafted with WGA as potential intravesical therapy of urinary tract infections-studies on adhesion to SV-HUCs under varying time, pH, and drug-loading conditions","volume":"5","author":"Brauner","year":"2020","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.mtbio.2025.102585_bib264","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3390\/pharmaceutics13091415","article-title":"Cannabidiol effectively promoted cell death in bladder cancer and the improved intravesical adhesion drugs delivery strategy could be better used for treatment","volume":"13","author":"Chen","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102585_bib265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106330","article-title":"LogP of N-acyl-gemcitabine and lectin-corona emerge as key parameters in nanoparticulate intravesical cancer therapy","volume":"180","author":"Anzengruber","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"36","key":"10.1016\/j.mtbio.2025.102585_bib266","doi-asserted-by":"crossref","first-page":"47192","DOI":"10.1021\/acsami.4c08770","article-title":"Swarms of enzymatic nanobots for efficient gene delivery","volume":"16","author":"Fraire","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102585_bib267","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/cells13070627","article-title":"Silencing the mitochondrial gatekeeper VDAC1 as a potential treatment for bladder cancer","volume":"13","author":"Alhozeel","year":"2024","journal-title":"Cells"},{"issue":"20","key":"10.1016\/j.mtbio.2025.102585_bib268","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012634","article-title":"Cabozantinib-loaded PLGA nanoparticles: a potential adjuvant strategy for surgically resected high-risk non-metastatic renal cell carcinoma","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib269","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100990","article-title":"Selective trafficking of light chain-conjugated nanoparticles to the kidney and renal cell carcinoma","volume":"35","author":"Ordikhani","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.mtbio.2025.102585_bib270","first-page":"8519","article-title":"Combined UTMD-nanoplatform for the effective delivery of drugs to treat renal cell carcinoma","volume":"19","author":"Dai","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib271","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.juro.2015.08.115","article-title":"Urinary exosomes: the potential for biomarker utility, intercellular signaling and therapeutics in urological malignancy","volume":"195","author":"Franzen","year":"2016","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib272","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12894-024-01540-6","article-title":"Unveiling potential: urinary exosomal mRNAs as non-invasive biomarkers for early prostate cancer diagnosis","volume":"24","author":"Yu","year":"2024","journal-title":"BMC Urol."},{"key":"10.1016\/j.mtbio.2025.102585_bib273","article-title":"Urinary exosomes diagnosis of urological tumors: a systematic review and meta-analysis","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2025.102585_bib274","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111581","article-title":"Injectable thermosensitive hydrogel-based drug delivery system for local cancer therapy","volume":"200","author":"Xiao","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib275","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jps.22309","article-title":"Thermosensitive hydrogels composed of hyaluronic acid and gelatin as carriers for the intravesical administration of cisplatin","volume":"100","author":"Chen","year":"2011","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib276","first-page":"315","article-title":"Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer","volume":"31","author":"Liu","year":"2024","journal-title":"Bioact. Mater."},{"issue":"12","key":"10.1016\/j.mtbio.2025.102585_bib277","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1039\/D3TB02837B","article-title":"Hydrogel: a new material for intravesical drug delivery after bladder cancer surgery","volume":"12","author":"Wu","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.mtbio.2025.102585_bib278","series-title":"Noble Metal-Metal Oxide Hybrid Nanoparticles","first-page":"3","article-title":"Chapter 1 - hybrid nanoparticles: an introduction","author":"Ma","year":"2019"},{"key":"10.1016\/j.mtbio.2025.102585_bib279","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","article-title":"Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance","volume":"7","author":"Yao","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib280","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-023-01849-0","article-title":"Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics","volume":"22","author":"Gajbhiye","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2025.102585_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.103007","article-title":"Core-shell inorganic NP@MOF nanostructures for targeted drug delivery and multimodal imaging-guided combination tumor treatment","volume":"321","author":"Khan","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib282","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jconrel.2019.01.009","article-title":"New insights into designing hybrid nanoparticles for lung cancer: diagnosis and treatment","volume":"295","author":"Mottaghitalab","year":"2019","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib283","article-title":"Hyperbaric oxygen regulates tumor pH to boost copper-doped hydroxyethyl starch conjugate nanoparticles against cancer stem cells","volume":"5","author":"Deng","year":"2025","journal-title":"Exploration (Beijing)"},{"issue":"14","key":"10.1016\/j.mtbio.2025.102585_bib284","article-title":"Engineered nanocatalyst-enabled cheolesterol depletion for enhanced tumor piezocatalytic therapy","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102585_bib285","article-title":"Programmed initiation and enhancement of cGAS\/STING pathway for tumour immunotherapy via tailor-designed ZnFe(2)O(4)-based nanosystem","volume":"3","author":"Yang","year":"2023","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.mtbio.2025.102585_bib286","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2147\/IJN.S347574","article-title":"Lactoferrin- and dendrimer-bearing gold nanocages for stimulus-free DNA delivery to prostate cancer cells","volume":"17","author":"Almowalad","year":"2022","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/j.mtbio.2025.102585_bib287","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3390\/pharmaceutics15082103","article-title":"Targeted doxorubicin-loaded dendronized gold nanoparticles","volume":"15","author":"Dockery","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102585_bib288","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122413","article-title":"Degradable multifunctional gold-liposomes as an all-in-one theranostic platform for image-guided radiotherapy","volume":"629","author":"Youden","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2025.102585_bib289","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.125539","article-title":"Targeted delivery of elesclomol using a magnetic mesoporous platform improves prostate cancer treatment both in vitro and in vivo","volume":"270","author":"Tarin","year":"2024","journal-title":"Talanta"},{"issue":"29","key":"10.1016\/j.mtbio.2025.102585_bib290","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2123527119","article-title":"Gd(2)O(3)-mesoporous silica\/gold nanoshells: a potential dual T(1)\/T(2) contrast agent for MRI-guided localized near-IR photothermal therapy","volume":"119","author":"Kadria-Vili","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib291","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12195","article-title":"Chimeric nanocomposites for the rapid and simple isolation of urinary extracellular vesicles","volume":"11","author":"Dao","year":"2022","journal-title":"J. Extracell. Vesicles"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102585_bib292","article-title":"Dual-enhanced SERS satellite immuno-nanocomplex for multiple PSA-mediated PHI assay toward clinical prostate cancer screening","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"17","key":"10.1016\/j.mtbio.2025.102585_bib293","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.3390\/ijms23179619","article-title":"Magnetofluoro-immunosensing platform based on binary nanoparticle-decorated graphene for detection of cancer cell-derived exosomes","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib294","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120641","article-title":"Enzyme-free sandwich-type electrochemical immunosensor for highly sensitive prostate specific antigen based on conjugation of quantum dots and antibody on surface of modified glassy carbon electrode with core-shell magnetic metal-organic frameworks","volume":"210","author":"Ehzari","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.mtbio.2025.102585_bib295","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122926","article-title":"Construction of a sensitive and selective plasmonic biosensor for prostate specific antigen by combining magnetic molecularly-imprinted polymer and surface-enhanced Raman spectroscopy","volume":"237","author":"Turan","year":"2022","journal-title":"Talanta"},{"key":"10.1016\/j.mtbio.2025.102585_bib296","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339387","article-title":"Confining copper nanoclusters in three dimensional mesoporous silica particles: fabrication of an enhanced emission platform for \"turn off-on\" detection of acid phosphatase activity","volume":"1192","author":"Chen","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.mtbio.2025.102585_bib297","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.2147\/IJN.S329621","article-title":"One-step microfluidic fabrication of multi-responsive liposomes for targeted delivery of doxorubicin synergism with photothermal effect","volume":"16","author":"Lv","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2025.102585_bib298","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110832","article-title":"Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy","volume":"189","author":"Wang","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"29\u201330","key":"10.1016\/j.mtbio.2025.102585_bib299","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1007\/s00216-022-04361-4","article-title":"Quantitative detection of urinary bladder cancer antigen via peptide-immobilized magnetic bead-based SERS probe","volume":"414","author":"Hou","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib300","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202102035","article-title":"Magnetic gold nanoparticles with idealized coating for enhanced point-of-care sensing","volume":"11","author":"Gessner","year":"2022","journal-title":"Adv. Healthcare Mater."},{"issue":"51","key":"10.1016\/j.mtbio.2025.102585_bib301","doi-asserted-by":"crossref","first-page":"18034","DOI":"10.1021\/acs.analchem.2c04408","article-title":"Noninvasive multiplexed analysis of bladder cancer-derived urine exosomes via Janus magnetic microspheres","volume":"94","author":"Wei","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mtbio.2025.102585_bib302","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.340302","article-title":"Self-calibration SERS sensor with \"core-satellite\" structure for detection of hyaluronidase activity","volume":"1227","author":"Chen","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.mtbio.2025.102585_bib303","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119377","article-title":"Magnetic-core-based silibinin nanopolymeric carriers for the treatment of renal cell cancer","volume":"275","author":"Takke","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib304","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.2147\/IJN.S215883","article-title":"Preparation of AS1411 aptamer modified Mn-MoS(2) QDs for targeted MR imaging and fluorescence labelling of renal cell carcinoma","volume":"14","author":"Zheng","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102585_bib305","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00604-022-05344-z","article-title":"Electrochemical \u03b1-fetoprotein immunosensor based on Fe(3)O(4)NPs@covalent organic framework decorated gold nanoparticles and magnetic nanoparticles including SiO(2)@TiO(2)","volume":"189","author":"B\u00f6l\u00fckba\u015fi","year":"2022","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.mtbio.2025.102585_bib306","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.341148","article-title":"Dual-targeting surface-enhancement Raman scattering tags based on silver nanocubes for early diagnosis of pheochromocytoma","volume":"1256","author":"Meng","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.mtbio.2025.102585_bib307","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bios.2017.08.046","article-title":"Construction of an ultrasensitive non-enzymatic sensor to investigate the dynamic process of superoxide anion release from living cells","volume":"100","author":"Wei","year":"2018","journal-title":"Biosens. Bioelectron."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib308","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib309","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/nano11040964","article-title":"Silver nanoparticles as carriers of anticancer drugs for efficient target treatment of cancer cells","volume":"11","author":"Gomes","year":"2021","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib310","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152317","article-title":"Nanoparticle-induced immune response: health risk versus treatment opportunity?","volume":"228","author":"Pondman","year":"2023","journal-title":"Immunobiology"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib311","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1021\/acs.molpharmaceut.4c00628","article-title":"Effect of Anti-PEG antibody on immune response of mRNA-Loaded lipid nanoparticles","volume":"21","author":"Omata","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mtbio.2025.102585_bib312","article-title":"Nanoparticle-induced complement activation: implications for cancer nanomedicine","volume":"11","author":"La-Beck","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2025.102585_bib313","article-title":"Size and dose of nanoparticles modulate between toxic and medicinal effect on kidney","volume":"16","author":"Nolte","year":"2024","journal-title":"Open"},{"key":"10.1016\/j.mtbio.2025.102585_bib314","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2024.105814","article-title":"Hemocompatibility studies in nanotoxicology: hemolysis or eryptosis? (A review)","volume":"98","author":"Tkachenko","year":"2024","journal-title":"Toxicol. Vitro"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","article-title":"Strategies to reduce the risks of mRNA drug and vaccine toxicity","volume":"23","author":"Bitounis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2025.102585_bib316","doi-asserted-by":"crossref","first-page":"112","DOI":"10.34133\/bmr.0112","article-title":"Impact of pre-existing anti-polyethylene glycol antibodies on the pharmacokinetics and efficacy of a COVID-19 mRNA vaccine (Comirnaty) in vivo","volume":"28","author":"Liu","year":"2024","journal-title":"Biomater. Res."},{"issue":"8","key":"10.1016\/j.mtbio.2025.102585_bib317","article-title":"Nanoparticles as drug delivery systems in intravesical therapy for non-muscle invasive bladder cancer: a narrative review","volume":"17","author":"G\u00f3rski","year":"2025","journal-title":"Cureus"},{"issue":"27","key":"10.1016\/j.mtbio.2025.102585_bib318","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1002\/chem.202005257","article-title":"Biological and medical applications of calcium phosphate nanoparticles","volume":"27","author":"Sokolova","year":"2021","journal-title":"Chemistry"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib319","article-title":"Recent advances in zwitterionic nanoscale drug delivery systems to overcome biological barriers","volume":"19","author":"Ouyang","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.mtbio.2025.102585_bib320","series-title":"Abx-Cro APSF","author":"Confirmatory","year":"2020"},{"key":"10.1016\/j.mtbio.2025.102585_bib321","series-title":"A Phase I-II dose-escalation Study of NBTXR3 Activated by EBRT or EBRT with Brachytherapy in Patients with Newly Diagnosed Unfavorable Intermediate or High Risk Prostate Adenocarcinoma Treated with Androgen Deprivation","year":"2016"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102585_bib322","first-page":"733","article-title":"Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer","volume":"33","author":"Mikhail","year":"2017","journal-title":"Int. J. Hyperther."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib323","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1093\/annonc\/mdx493","article-title":"A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma","volume":"28","author":"Voss","year":"2017","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102585_bib324","first-page":"613","article-title":"FDA approves landmark RNAi drug","volume":"17","author":"Mullard","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2025.102585_bib325","article-title":"Progress on drug nanoparticle manufacturing: exploring the adaptability of batch bottom-up approaches to continuous manufacturing","volume":"111","author":"Costa","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"12","key":"10.1016\/j.mtbio.2025.102585_bib326","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.xphs.2024.09.005","article-title":"Current state of nanomedicine drug products: an industry perspective","volume":"113","author":"Clogston","year":"2024","journal-title":"J. Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib327","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1021\/acs.chemrev.2c00822","article-title":"Rational design of biomaterials to potentiate cancer thermal therapy","volume":"123","author":"Zhu","year":"2023","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102585_bib328","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202108908","article-title":"Reshaping the tumor immune microenvironment based on a light-activated nanoplatform for efficient cancer therapy","volume":"34","author":"Yang","year":"2022","journal-title":"Adv. Mater."},{"issue":"14","key":"10.1016\/j.mtbio.2025.102585_bib329","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309355","article-title":"Personalized cancer nanomedicine: overcoming biological barriers for intracellular delivery of biopharmaceuticals","volume":"36","author":"L\u00f3pez-Est\u00e9vez","year":"2024","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib330","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s12672-025-03070-5","article-title":"mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities","volume":"16","author":"Lv","year":"2025","journal-title":"Discov. Oncol."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102585_bib331","doi-asserted-by":"crossref","DOI":"10.1097\/ot9.0000000000000014","article-title":"Development of therapeutic cancer vaccines using nanomicellar preparations","volume":"9","author":"Qin","year":"2023","journal-title":"Oncology and Translational Medicine"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102585_bib332","doi-asserted-by":"crossref","DOI":"10.1097\/ot9.0000000000000074","article-title":"Advances in immunotherapy and targeted therapy for pancreatic cancer","volume":"11","author":"Zhou","year":"2025","journal-title":"Oncology and Translational Medicine"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102585_bib333","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1021\/acsnano.4c09566","article-title":"Transforming medicine: cutting-edge applications of nanoscale materials in drug delivery","volume":"19","author":"Tenchov","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.102585_bib334","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2021.100492","article-title":"Oncology drug-companion diagnostic combinations","volume":"29","author":"J\u00f8rgensen","year":"2021","journal-title":"Cancer Treatment and Research Communications"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102585_bib335","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-025-00602-1","article-title":"Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects","volume":"14","author":"Cheng","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.mtbio.2025.102585_bib336","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1021\/acs.nanolett.9b01774","article-title":"Precision nanomedicine development based on specific opsonization of human cancer patient-personalized protein coronas","volume":"19","author":"Ren","year":"2019","journal-title":"Nano Lett."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425011561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425011561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:51:17Z","timestamp":1773834677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425011561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":336,"alternative-id":["S2590006425011561"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102585","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle-based drug delivery systems in urologic oncology: From targeted therapy to precision theranostics","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102585"}}